Trever Bivona

Trever Bivona

Company: University of California San Francisco

Job title: Professor - Hematology & Oncology


Join me at Wnt


Wnt/β-Catenin Signaling Promotes Drug Tolerance & Resistance to Targeted Cancer Therapy 12:10 pm

• Discuss how targeted cancer therapy is associated with activation of Wnt/β-catenin signaling • Find out how Wnt/β-catenin signaling supports lineage plasticity during treatment • Analyze how inhibiting Wnt/β-catenin signaling blocks this drug tolerance and resistance process and enhances response to targeted cancer therapyRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.